Cryptococcosis in patients with myasthenia gravis: clinical characteristics and management strategy
The management of cryptococcal infection in patients with MG poses significant challenges in the context of underlying immune dysfunction and the use of immunosuppressive therapy. Within this complex clinical scenario, early recognition, multidisciplinary care, and individualized treatment strategies are paramount. They underscore the need for heightened clinical vigilance and further research to optimize outcomes in this vulnerable patient population.
Authors
- Ce Zhang (ORCID: https://orcid.org/0000-0001-7350-4187)
- Chuan Shen (ORCID: https://orcid.org/0000-0002-1317-8866)
- Mengyao Lv
- Qian Zhao (ORCID: https://orcid.org/0000-0003-4489-3691)
- Luyuan Ma (ORCID: https://orcid.org/0000-0002-1816-5175)
- Shu Wang (ORCID: https://orcid.org/0000-0001-7347-4707)
- Qiuting Wang (ORCID: https://orcid.org/0000-0003-3019-1429)
- Caiyan Zhao (ORCID: https://orcid.org/0000-0001-5997-4641)
- Chengshuai Yang
- Xiaotong Zhang (ORCID: https://orcid.org/0009-0003-2636-2149)
- Ziyue Li (ORCID: https://orcid.org/0000-0002-7393-1442)
Institutions
- Hebei Medical University (CN)
- Third Hospital of Hebei Medical University (CN)
- Hebei Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-10-30
- DOI
- https://doi.org/10.3389/fcimb.2025.1653458
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00